These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
497 related articles for article (PubMed ID: 16204463)
1. Determination of the enzyme(s) involved in the metabolism of amiodarone in liver and intestine of rat: the contribution of cytochrome P450 3A isoforms. Shayeganpour A; El-Kadi AO; Brocks DR Drug Metab Dispos; 2006 Jan; 34(1):43-50. PubMed ID: 16204463 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of desethylamiodarone in the rat after its administration as the preformed metabolite, and after administration of amiodarone. Shayeganpour A; Hamdy DA; Brocks DR Biopharm Drug Dispos; 2008 Apr; 29(3):159-66. PubMed ID: 18161885 [TBL] [Abstract][Full Text] [Related]
3. In vitro metabolism of amiodarone by rabbit and rat liver and small intestine. Young RA; Mehendale HM Drug Metab Dispos; 1986; 14(4):423-9. PubMed ID: 2873989 [TBL] [Abstract][Full Text] [Related]
4. Effects of short-term and long-term pretreatment of Schisandra lignans on regulating hepatic and intestinal CYP3A in rats. Lai L; Hao H; Wang Q; Zheng C; Zhou F; Liu Y; Wang Y; Yu G; Kang A; Peng Y; Wang G; Chen X Drug Metab Dispos; 2009 Dec; 37(12):2399-407. PubMed ID: 19741040 [TBL] [Abstract][Full Text] [Related]
5. Effect of cytochrome P-450 and flavin-containing monooxygenase modifying factors on the in vitro metabolism of amiodarone by rat and rabbit. Young RA; Mehendale HM Drug Metab Dispos; 1987; 15(4):511-7. PubMed ID: 2888625 [TBL] [Abstract][Full Text] [Related]
6. The impact of experimental hyperlipidemia on the distribution and metabolism of amiodarone in rat. Shayeganpour A; Korashy H; Patel JP; El-Kadi AO; Brocks DR Int J Pharm; 2008 Sep; 361(1-2):78-86. PubMed ID: 18599227 [TBL] [Abstract][Full Text] [Related]
7. The stereoselective metabolism of halofantrine to desbutylhalofantrine in the rat: evidence of tissue-specific enantioselectivity in microsomal metabolism. Gharavi N; Sattari S; Shayeganpour A; El-Kadi AO; Brocks DR Chirality; 2007 Jan; 19(1):22-33. PubMed ID: 17089336 [TBL] [Abstract][Full Text] [Related]
8. Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine. Martignoni M; Groothuis G; de Kanter R Drug Metab Dispos; 2006 Jun; 34(6):1047-54. PubMed ID: 16565172 [TBL] [Abstract][Full Text] [Related]
9. Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole. Tsunoda SM; Velez RL; von Moltke LL; Greenblatt DJ Clin Pharmacol Ther; 1999 Nov; 66(5):461-71. PubMed ID: 10579473 [TBL] [Abstract][Full Text] [Related]
10. Effects of ketoconazole on the intestinal metabolism, transport and oral bioavailability of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor and a P450 3A, P-glycoprotein dual substrate, in male Sprague-Dawley rats. Zhang Y; Hsieh Y; Izumi T; Lin ET; Benet LZ J Pharmacol Exp Ther; 1998 Oct; 287(1):246-52. PubMed ID: 9765344 [TBL] [Abstract][Full Text] [Related]
11. Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping. Lee JI; Chaves-Gnecco D; Amico JA; Kroboth PD; Wilson JW; Frye RF Clin Pharmacol Ther; 2002 Dec; 72(6):718-28. PubMed ID: 12496753 [TBL] [Abstract][Full Text] [Related]
12. Single-dose kinetics of tissue distribution, excretion and metabolism of amiodarone in rats. Wyss PA; Moor MJ; Bickel MH J Pharmacol Exp Ther; 1990 Aug; 254(2):502-7. PubMed ID: 2384884 [TBL] [Abstract][Full Text] [Related]
13. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes. Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451 [TBL] [Abstract][Full Text] [Related]
14. Characterization of metabolites and cytochrome P450 isoforms involved in the microsomal metabolism of aconitine. Wang Y; Wang S; Liu Y; Yan L; Dou G; Gao Y J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Dec; 844(2):292-300. PubMed ID: 16949890 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the cytochrome P450 enzymes and enzyme kinetic parameters for metabolism of BVT.2938 using different in vitro systems. Baranczewski P; Edlund PO; Postlind H J Pharm Biomed Anal; 2006 Mar; 40(5):1121-30. PubMed ID: 16307862 [TBL] [Abstract][Full Text] [Related]
16. The metabolism of amiodarone by various CYP isoenzymes of human and rat, and the inhibitory influence of ketoconazole. Elsherbiny ME; El-Kadi AO; Brocks DR J Pharm Pharm Sci; 2008; 11(1):147-59. PubMed ID: 18445370 [TBL] [Abstract][Full Text] [Related]
17. The effect of CYP1A induction on amiodarone disposition in the rat. Elsherbiny ME; Brocks DR J Pharm Sci; 2010 Jan; 99(1):539-48. PubMed ID: 19718765 [TBL] [Abstract][Full Text] [Related]
18. [Study on metabolism of tetramethylpyrazine in system of rat liver microsomes]. Kuang XD; Li XH; Xiong YQ Zhongguo Zhong Yao Za Zhi; 2006 Dec; 31(23):1971-5. PubMed ID: 17348193 [TBL] [Abstract][Full Text] [Related]
19. The effect of beta-naphthoflavone on the metabolism of amiodarone by hepatic and extra-hepatic microsomes. Elsherbiny ME; El-Kadi AO; Brocks DR Toxicol Lett; 2010 Jun; 195(2-3):147-54. PubMed ID: 20362646 [TBL] [Abstract][Full Text] [Related]
20. Differential metabolism of midazolam in mouse liver and intestine microsomes: a comparison of cytochrome P450 activity and expression. Perloff MD; Von Moltke LL; Greenblatt DJ Xenobiotica; 2003 Apr; 33(4):365-77. PubMed ID: 12745872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]